Truist Financial Corp trimmed its stake in Stericycle, Inc. (NASDAQ:SRCL – Free Report) by 39.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,723 shares of the business services provider’s stock after selling 5,640 shares during the quarter. Truist Financial Corp’s holdings in Stericycle were worth $432,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. Park Avenue Securities LLC purchased a new position in Stericycle in the 3rd quarter valued at about $256,000. Noesis Capital Mangement Corp boosted its position in Stericycle by 89.0% during the third quarter. Noesis Capital Mangement Corp now owns 212,850 shares of the business services provider’s stock worth $9,517,000 after acquiring an additional 100,257 shares during the last quarter. Arizona State Retirement System grew its stake in Stericycle by 1.4% in the 3rd quarter. Arizona State Retirement System now owns 26,322 shares of the business services provider’s stock worth $1,177,000 after acquiring an additional 358 shares during the period. Equitable Trust Co. raised its holdings in Stericycle by 8.7% in the 3rd quarter. Equitable Trust Co. now owns 6,647 shares of the business services provider’s stock valued at $297,000 after acquiring an additional 531 shares during the last quarter. Finally, Barclays PLC raised its holdings in Stericycle by 30.6% in the 3rd quarter. Barclays PLC now owns 70,408 shares of the business services provider’s stock valued at $3,147,000 after acquiring an additional 16,505 shares during the last quarter. 98.82% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of brokerages have recently commented on SRCL. Stifel Nicolaus lifted their price objective on Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a research report on Thursday, February 29th. Robert W. Baird dropped their price objective on shares of Stericycle from $62.00 to $55.00 and set a “neutral” rating for the company in a research note on Friday, April 26th. Truist Financial lowered their target price on shares of Stericycle from $57.00 to $50.00 and set a “hold” rating for the company in a report on Monday, April 29th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $69.00 price target on shares of Stericycle in a research report on Thursday, March 7th. Finally, StockNews.com lowered shares of Stericycle from a “buy” rating to a “hold” rating in a report on Tuesday, April 2nd. One analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Stericycle presently has an average rating of “Hold” and an average price target of $59.40.
Get Our Latest Stock Analysis on Stericycle
Stericycle Trading Down 0.5 %
Shares of SRCL stock opened at $46.53 on Friday. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.55. Stericycle, Inc. has a fifty-two week low of $37.78 and a fifty-two week high of $57.06. The firm’s 50 day moving average price is $49.69 and its two-hundred day moving average price is $48.72. The stock has a market cap of $4.32 billion, a price-to-earnings ratio of -211.50, a price-to-earnings-growth ratio of 2.52 and a beta of 1.12.
Stericycle (NASDAQ:SRCL – Get Free Report) last posted its earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.03. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The business had revenue of $664.90 million for the quarter, compared to analyst estimates of $676.42 million. During the same quarter in the previous year, the business posted $0.49 EPS. The business’s quarterly revenue was down 2.8% on a year-over-year basis. On average, analysts anticipate that Stericycle, Inc. will post 2.32 EPS for the current year.
Stericycle Company Profile
Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.
Further Reading
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle, Inc. (NASDAQ:SRCL – Free Report).
Receive News & Ratings for Stericycle Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Stericycle and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
